Dhanuka Agritech Ltd

The board of Dhanuka Agritech at its meeting held on 31 October 2025 has approved the purchase of land at Nagpur, Maharashtra for setting up a formulation plant. Powered by Capital Market - Live

Net profit of Dhanuka Agritech declined 20.04% to Rs 93.97 crore in the quarter ended September 2025 as against Rs 117.52 crore during the previous quarter ended September 2024. Sales declined 8.56% to Rs 598.25 crore in the quarter ended September 2025 as against Rs 654.28 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales598.25654.28 -9 OPM %22.8624.39 - PBDT142.24169.33 -16 PBT125.98156.66 -20 NP93.97117.52 -20 Powered by Capital Market - Live

Dhanuka Agritech will hold a meeting of the Board of Directors of the Company on 31 October 2025.Powered by Capital Market - Live

The agency has also affirmed the rating on the short-term bank facilities at 'CARE A1+'. CARE Ratings stated that the ratings affirmation of bank facilities of Dhanuka Agritech (DAL) continues to reflect its established position in the agrochemical sector, backed by long operating track record, experienced management, and enduring partnerships with reputed multinational players that provide access to specialty molecules and also support the company's operating margins to a large extent. A diversified product portfolio across insecticides, herbicides, and fungicides, with a wide geographical footprint, enables the company to serve a large farmer base and reduce concentration risks. Ratings also draw comfort from DAL's strong financial risk profile, characterised by a robust capital structure, low gearing, strong debt coverage metrics, and healthy profitability. Liquidity remains strong, supported by sizeable cash accruals, surplus liquid investments, low dependence on external debt, and sufficient headroom to fund growth requirements. CARE Ratings further notes DAL's recent acquisition of active ingredients Iprovalicarb and Triadimenol from Bayer AG which is expected to strengthen DAL's global positioning and widen its product base, though revenue contribution from these molecules will remain a key monitorable in the near term. However, ratings remain constrained by the company's exposure to the inherently competitive and regulated crop protection industry, vulnerability to climatic variations, and risks associated with raw material price volatility and policy changes. Profitability was partly moderated by underutilisation at the newly commissioned Dahej plant, with improvement in capacity utilisation remaining a key monitorable. Dhanuka Agritech is engaged in manufacturing formulations and technical in agro-chemicals segment such as insecticides, pesticides, and herbicides, among others, through its manufacturing facilities at Sanand (Gujarat), Udhampur (Jammu and Kashmir), Keshwana (Rajasthan), and Dahej (Gujarat), respectively. The company's standalone net profit rose 13.50% to Rs 55.50 crore on a 7.03% increase in revenue to Rs 528.29 crore in Q1 FY26 over Q1 FY25. The scrip fell 1.02% to currently trade at Rs 1589.20 on the BSE. Powered by Capital Market - Live

Dhanuka Agritech announced that CARE Ratings has reaffirmed the ratings of the Company's bank facilities as 'CARE AA; Stable' for long-term bank facilities and 'CARE A1+' for short-term bank facilities. Powered by Capital Market - Live

Dhanuka Agritech announced that Sujoy Chakrabarti has been appointed as Senior Management Personnel under the designation Vice President- Sales of the Company w.e.f. 11 August 2025. Powered by Capital Market - Live

Net profit of Dhanuka Agritech rose 13.50% to Rs 55.50 crore in the quarter ended June 2025 as against Rs 48.90 crore during the previous quarter ended June 2024. Sales rose 7.03% to Rs 528.29 crore in the quarter ended June 2025 as against Rs 493.58 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales528.29493.58 7 OPM %15.7514.53 - PBDT89.9378.03 15 PBT74.5465.75 13 NP55.5048.90 13 Powered by Capital Market - Live

Dhanuka Agritech will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live

Net profit of Dhanuka Agritech rose 27.92% to Rs 75.50 crore in the quarter ended March 2025 as against Rs 59.02 crore during the previous quarter ended March 2024. Sales rose 20.01% to Rs 442.02 crore in the quarter ended March 2025 as against Rs 368.31 crore during the previous quarter ended March 2024. For the full year,net profit rose 24.20% to Rs 296.96 crore in the year ended March 2025 as against Rs 239.09 crore during the previous year ended March 2024. Sales rose 15.73% to Rs 2035.15 crore in the year ended March 2025 as against Rs 1758.54 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales442.02368.31 20 2035.151758.54 16 OPM %24.8321.75 -20.4718.62 - PBDT119.1194.67 26 447.60359.32 25 PBT101.6681.50 25 392.14318.75 23 NP75.5059.02 28 296.96239.09 24 Powered by Capital Market - Live

Revenue from operations rose 20.01% YoY to Rs 442.02 crore in the quarter ended 31 March 2025. Profit before tax grew 24.73% to Rs 101.66 crore in Q4 FY25 from Rs 81.50 crore in Q4 FY24. On a full-year basis, the company's consolidated net profit rose 24.20% to Rs 296.96 crore on a 15.72% increase in revenue from operations to Rs 2,035.15 crore in FY25 over FY24. Meanwhile, the company's board has recommended a final dividend of Rs 2 per equity share, subject to approval by the members at the 40th Annual General Meeting (AGM). If approved, the dividend will be paid within 30 days of the AGM. The record date for determining eligibility for the final dividend is 18 July 2025. Dhanuka Agritech is an agrochemical company. The company has 3 manufacturing units with 39 warehouses and network of over 8 branch offices across the Indian geography that caters to 6,500 distributors & approximately 75,000 dealers. Powered by Capital Market - Live